Tech Company Financing Transactions

Sarcura Funding Round

Sarcura secured a $7.2 million Seed venture capital round on 11/19/2022. Backers included IST cube Management, Lansdowne Investment Company Cyprus and Axilium Holding.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

Plöcking 2, IST Park
Klosterneuburg, 340
AT

Phone

Undisclosed

Website

www.sarcura.com/

Email Address

Undisclosed

Overview

Sarcura develops a machine platform for the large scale, industrial manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments from thousands of doses per year to hundreds of thousands, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technology to bring bioprocess control to cellular level.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Daniela Buchmayr

        

Co-Founder

Franz Emminger

        

Co-Founder

Martin Fischlechner

        

Co-Founder

Erwin Gorjup

        

Browse more venture capital transactions:

Prev: 11/18/2022: Continuum Supply venture capital transaction
Next: 11/20/2022: WeGift venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document all VC transactions involving tech companies. All VC database entries reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary